Citations

Showing 10 of 108094 citations.

Determining the time frame of maximum clinical improvement in surgical decompression for cervical spondylotic myelopathy when stratified by preoperative myelopathy severity: a cervical Quality Outcomes Database study
Berlin, Connor , Marino, Alexandria C. , Mummaneni, Praveen V. , Uribe, Juan S. , Tumialán, Luis M. , Turner, Jay D. , Wang, Michael Y. , Park, Paul , Bisson, Erica F. , Shaffrey, Mark E., Gottfried, Oren N., Than, Khoi D. , Fu, Kai-Ming, Foley, Kevin T. , Chan, Andrew K. , Bydon, Mohamad , Upadhyaya, Cheerag D., Coric, Domagoj , Asher, Anthony L. , Potts, Eric A. , Knightly, John J. , Meyer, Scott A., Buchholz, Avery L., Uribe, Juan S. , Alvi, Mohammed Ali

Mayo Clinic

Journal of Neurosurgery: Spine | June 24, 2022 | Volume: 37 | Issue: 5 | Pages: 758-766

10.3171/2022.5.spine211425 | PMID 35901760 Get It

OBJECTIVE While surgical decompression is an important treatment modality for cervical spondylotic myelopathy (CSM), it remains unclear if the severity of preoperative myelopathy status affects potential benefit from surgical intervention and when maximum postoperative improvement is expected. This investigation sought to determine if retrospective analysis of prospectively collected patient-reported outcomes (PROs) following surgery for CSM differed when stratified by preoperative myelopathy status. Secondary objectives included assessment of the minimal clinically important difference (MCID). METHODS A total of 1151 patients with CSM were prospectively enrolled from the Quality Outcomes Database at 14 US hospitals. Baseline demographics and PROs at baseline and 3 and 12 months were measured. These included the modified Japanese Orthopaedic Association (mJOA) score, Neck Disability Index (NDI), quality-adjusted life-years (QALYs) from the EQ-5D, and visual analog scale from the EQ-5D (EQ-VAS). Patients were stratified by preoperative myelopathy severity using criteria established by the AO Spine study group: mild (mJOA score 15–17), moderate (mJOA score 12–14), or severe (mJOA score < 12). Univariate analysis was used to identify demographic variables that significantly varied between myelopathy groups. Then, multivariate linear regression and linear mixed regression were used to model the effect of severity and time on PROs, respectively. RESULTS For NDI, EQ-VAS, and QALY, patients in all myelopathy cohorts achieved significant, maximal improvement at 3 months without further improvement at 12 months. For mJOA, moderate and severe myelopathy groups demonstrated significant, maximal improvement at 3 months, without further improvement at 12 months. The mild myelopathy group did not demonstrate significant change in mJOA score but did maintain and achieve higher PRO scores overall when compared with more advanced myelopathy cohorts. The MCID threshold was reached in all myelopathy cohorts at 3 months for mJOA, NDI, EQ-VAS, and QALY, with the only exception being mild myelopathy QALY at 3 months. CONCLUSIONS As assessed by statistical regression and MCID analysis, patients with cervical myelopathy experience maximal improvement in their quality of life, neck disability, myelopathy score, and overall health by 3 months after surgical decompression, regardless of their baseline myelopathy severity. An exception was seen for the mJOA score in the mild myelopathy cohort, improvement of which may have been limited by ceiling effect. The data presented here will aid surgeons in patient selection, preoperative counseling, and expected postoperative time courses.
Rescue therapy with novel waveform spinal cord stimulation for patients with failed back surgery syndrome refractory to conventional stimulation: a systematic review and meta-analysis
Sammak, Sally El , Michalopoulos, Giorgos D. , Romero, Joshua , Ha, Christopher T., Bydon, Mohamad , Mualem, William , Hunt, Christine L., Michalopoulos, Giorgos , Hunt, Christine

Mayo Clinic

Journal of Neurosurgery: Spine | June 24, 2022 | Volume: 37 | Issue: 5 | Pages: 670-679

10.3171/2022.4.spine22331 | PMID 36303477 Get It

OBJECTIVE Conventional spinal cord stimulators (SCSs) have demonstrated efficacy in individuals with failed back surgery syndrome (FBSS). However, a subgroup of patients may become refractory to the effects of conventional waveforms over time. The objective of this study was to systematically review and evaluate the current literature on the use of novel waveform spinal cord stimulation for the management of FBSS refractory to conventional SCSs. METHODS A comprehensive electronic search of the literature published in electronic databases, including Ovid MEDLINE and Epub Ahead of Print, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus, was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The outcomes of interest were reduction in back pain and/or leg pain after conversion from conventional to novel SCSs. Risk of bias was assessed with the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) tool. The strength of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) criteria. RESULTS A total of 6 studies with 137 patients with FBSS were identified. Studies were published between 2013 and 2021. The mean ± SD age of the pooled patient sample was 55 ± 10.5 years. All patients who underwent treatment with conventional SCSs were identified. Two studies evaluated the efficacy of high-density spinal cord stimulation, 3 studies evaluated burst spinal cord stimulation, and 1 study assessed multimodal waveforms. The mean difference in back pain scores after conversion from a standard SCS to a novel waveform SCS was 2.55 (95% CI 1.59–4.08), demonstrating a significant reduction in back pain after conversion to novel stimulation. The authors also performed a subgroup analysis to compare burst stimulation to tonic waveforms. In this analysis, the authors found no significant difference in the average reductions in back pain between the 2 groups (p = 0.534).The authors found an I2 statistic equivalent to 98.47% in the meta-regression model used to assess the effect of follow-up duration on study outcome; this value implied that the variability in the data can be attributed to the remaining between-study heterogeneity. The overall certainty was moderate, with a high risk of bias across studies. CONCLUSIONS Rescue therapy with novel waveform spinal cord stimulation is a potential option for pain reduction in patients who become refractory to conventional SCSs. Conversion to novel waveform SCSs may potentially mitigate expenses and complications.
Semiautomated intraoperative measurement of Cobb angle and coronal C7 plumb line using deep learning and computer vision for scoliosis correction: a feasibility study
Gami, Parth, Qiu, Kelly, Kannappan, Sindhu, Alperin, Yoel, Buchanan, Ian A. , Quiñones‐Hinojosa, Alfredo , Biase, Gaetano De , Abode-Iyamah, Kingsley

Mayo Clinic

Journal of Neurosurgery: Spine | June 24, 2022 | Volume: 37 | Issue: 5 | Pages: 713-721

10.3171/2022.4.spine22133 | PMID 36303475 Get It

OBJECTIVE Scoliosis is a degenerative disease with a 3D deformity in the alignment of the spinal column. Surgical spinal correction outcomes are heavily dependent on the surgeon’s expertise and use of visual cues because of time requirements, lack of automation, and radiation exposure associated with current intraoperative measurement techniques. In this study, the authors sought to validate a novel, nonradiographic, and semiautomated device that measures spinal alignment intraoperatively using deep learning and computer vision. METHODS To obtain spinal alignment metrics intraoperatively, the surgeon placed 3D-printed markers made of acrylonitrile butadiene styrene (ABS) plastic at designated locations in the surgical field. With the high-definition camera of the device, the surgeon can take an image of the markers in the surgical field. Images are processed through a computer vision model that detects the location of the markers and calculates the Cobb angle and coronal plumb line. The marker detection model was trained on 100 images and tested on 130 images of the ABS markers in various conditions. To verify the Cobb angle calculation, 50 models of angle templates from 0° to 180° in 3.6735° increments were created for testing. To verify the plumb line calculation, 21 models of plumb line measurements from −10 to +10 cm in increments of 1 cm were created for testing. A validation study was performed on a scoliotic cadaver model, and the radiographic calculations for Cobb angle and plumb line were compared with the device’s calculations. RESULTS The area under the curve for the marker detection model was 0.979 for Cobb angle white, 0.791 for Cobb angle black, and 1 for the plumb line model. The average absolute difference between expected and measured Cobb angles on the verification models was 1.726° ± 1.259°, within the clinical acceptable error of 5°. The average absolute difference between the expected and measured plumb lines on the verification models was 0.415 ± 0.255 cm. For the cadaver validation study, the differences between the radiographic and device calculations for the Cobb angle and plumb line were 2.78° and 0.29 cm, respectively. CONCLUSIONS The authors developed and validated a nonradiographic, semiautomated device that utilizes deep learning and computer vision to measure spinal metrics intraoperatively.
P1552: A PHASE 2, OPEN-LABEL STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFECT OF ANX005 IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA AND EVIDENCE OF COMPLEMENT ACTIVATION
Jaeger, U., Broome, C., Go, R., Patriarca, A., Roeth, A., Chang, Q., Weedin, N., Adams, P., Cahir-McFarland, E., Kroon, H.-A., Jaeger, Ulrich, Patriarca, A., Roeth, A, Kroon, H.-A.

Mayo Clinic

HemaSphere | June 24, 2022 | Volume: 6 | Issue: No issue available | Pages: 1433-1434

10.1097/01.hs9.0000849064.31599.55 Get It

Can COVID-19 worsen racial disparities in breast cancer screening and diagnosis?
Yacona, Kate, Hanna, Mariam , Niyazi, Sara, Hatch, Parlyn, Hernandez, Mauricio , Letter, Haley , Sharma, Smita

Mayo Clinic

Journal of Clinical Imaging Science | June 24, 2022 | Volume: 12 | Issue: No issue available | Pages: 35

10.25259/jcis_26_2022 | PMID 36128359 Get It

Background Health disparities among minority groups, especially African Americans, can limit their access to quality medical care and lead to disproportionate medical management and disease outcomes. The aim of this study was to compare the COVID-19-related change in mammogram volumes and cancer detection at two affiliated academic breast centers, one that serves a predominantly African American patient population and one that serves a predominantly non-African American patient population. Materials and methods For the purpose of anonymity, racial demographics were collected and the center with a higher African American patient population was designated as institution A, while the center with a higher non-African American patient population was designated as institution B. Careful selection of the two breast centers was instituted in order to limit the impact of potential confounders other than race. An Institutional Review Board (IRB) exemption was obtained and two Mammography Quality Standards Act (MQSA) reports were generated; one for March 2020 through September 2020, during the height of the COVID-19 pandemic, and one for March 2019 through September 2019 to serve as the pre-pandemic control group. The i2b2 Query Analysis Tool® was used to obtain racial demographic data and compare the percent change in screening and diagnostic mammograms, image-guided biopsies, total cancers diagnosed by imaging, and percent of minimal cancers for both institutions. Results Screening mammograms and breast cancer detection decreased in 2020 compared to 2019 at both institutions. However, the percent change from 2019 to 2020 was greater at institution A than at institution B. Percent minimal cancers, an indicator of early-stage breast cancer also decreased more drastically at institution A than at institution B. Interestingly, the total number of diagnostic exams and image-guided biopsies increased in 2020 at institution B, whereas both decreased at institution A. Conclusion The COVID-19 pandemic may lead to worsening racial disparities in breast cancer screening. In an effort to narrow future disparity, it is crucial for radiologists and other health care providers to be aware of this inequality and educate all women on the importance of obtaining routine screening mammography. More studies are needed.
Exuberant late gadolinium enhancement in hypertrophic cardiomyopathy as a precursor to ‘burn out’
Gweun, John , Thomas, Sarah , Geske, Jeffrey B. , Geske, Jeffrey B , Thomas, Sarah C

Mayo Clinic

European Heart Journal - Case Reports | June 24, 2022 | Volume: 6 | Issue: 6 | Pages: No page available

10.1093/ehjcr/ytac243 | PMID 35775015 Get It

PB1888: EFFICACY OF FIRST-LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A BAYESIANNETWORK META-ANALYSIS.
Chanan-Khan, A., Yang, Kaiqian, Liu, T., Cohen, A., Fahrbach, K., Wang, Y., Tang, B., Chanan‐Khan, A.A., Liu, T., Fahrbach, Kyle , Tang, B

Mayo Clinic

HemaSphere | June 24, 2022 | Volume: 6 | Issue: No issue available | Pages: 1767-1768

10.1097/01.hs9.0000850404.50582.cb Get It

Fluid management in hospitalized pediatric patients
Alexander, Erin , Weatherhead, Jeffrey , Creo, Ana L. , Hanna, Christian , Steien, Dana B. , Creo, Ana , Hanna, Christian

Mayo Clinic

Nutrition in Clinical Practice | June 24, 2022 | Volume: 37 | Issue: 5 | Pages: 1033-1049

10.1002/ncp.10876 | PMID 35748381 Get It

AbstractThe proper use of intravenous fluids has likely been responsible for saving more lives than any other group of substances. Proper use includes prescribing an appropriate electrolyte and carbohydrate solution, at a calculated rate or volume, for the right child, at the right time. Forming intravenous fluid plans for hospitalized children requires an understanding of water and electrolyte physiology in healthy children and how different pathology deviates from the norm. This review highlights fluid management in several disease types, including liver disease, diabetic ketoacidosis, syndrome of inappropriate antidiuretic hormone, diabetes insipidus, kidney disease, and intestinal failure as well as in those with nonphysiologic fluid losses. For each disease, the review discusses specific considerations, evaluations, and management strategies to consider when customizing intravenous fluid plans. Ultimately, all hospitalized children should receive an individualized fluid plan with recurrent evaluations and fluid modifications to provide optimal care.
Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019
Razonable, Raymund R. , Bishop, Rachel, Culbertson, Tracy L, Borgen, Molly Destro, Hedin, Michelle C., Hopkins, Laura H., Jackson, Tammy A., Larsen, Jennifer J., Matoush, Jennifer A., Moehnke, Darcie E. , Olson, Shelly M., Peterson, Kellie M, Rosedahl, Jordan K., Bishop, Rachel K, Destro Borgen, Molly, Moehnke, Darcie E , Rosedahl, Jordan, Razonable, Raymund R , Ganesh, Ravindra , Borgen, Molly J. Destro, Philpot, Lindsey M.

Mayo Clinic

Journal of Patient Experience | June 24, 2022 | Volume: 9 | Issue: No issue available | Pages: No page available

10.1177/23743735221105673 | PMID 35769314 Get It

Anti-spike monoclonal antibodies emerged as effective early treatment of high-risk individuals with mild-to-moderate COVID-19. Although their clinical and safety outcomes have been reported, patient perspectives of these experimental therapies have not been evaluated. In this survey participated by 644/2412 (26.7% response) individuals evaluated for anti-spike monoclonal antibody therapies, the majority of 523 patients who received the antibody infusion were very satisfied with their overall patient experience, the quality of care provided, and various aspects of medical care. They voiced satisfaction with the communication with providers before and during treatment, including education provided about monoclonal antibody treatment, the potential benefits and adverse effects, detailed instructions on the process of infusion, and safety protocols employed at the infusion facilities. Nearly a quarter (23.6%) of 121 patients who declined therapy indicated they would accept treatment should it be offered again. These patient perspectives may be used to guide healthcare facilities and providers in optimizing the care provided to high-risk outpatients with COVID-19.
Cardiac Rhabdoid Tumor—A Rare Foe—Case Report and Literature Review
Luca, Alina-Costina , Miron, Ingrith , Cojocaru, Elena , Țarcă, Elena , Curpăn, Alexandrina-Ștefania , Mihăila, Doina, Trandafir, Laura Mihaela , Iordache, Alin-Constantin, Lupu, Vasile Valeriu , Tazelaar, Henry D. , Pădureț, Ioana Alexandra , Miron, Ingrith Crenguța , Mihăilă, Doina, Tazelaar, Henry D.

Mayo Clinic

Children | June 23, 2022 | Volume: 9 | Issue: 7 | Pages: 942

10.3390/children9070942 | PMID 35883926 Get It

Intracardiac masses are unusual findings in infants, and most of them are benign. Nevertheless, they may be associated with a significant degree of hemodynamic instability and/or arrhythmias. Malignant tumors of the heart rarely occur in children. Rhabdoid tumors are aggressive tumors with a dismal prognosis even when diagnosed early. Although rhabdomyomas are common cardiac tumors in infants, they are mostly benign. The most common sites of involvement are the kidneys and central nervous system, but soft tissues, lungs, and ovaries may also be affected. The diagnosis can be challenging, particularly in sites where they do not usually occur. In the present paper, we report the case of a 2-year-old boy diagnosed with cardiac rhabdoid tumor highlighting the importance of molecular studies and recent genetic discoveries with the purpose of improving the management of such cases. The aim of this educational case report and literature review is to raise awareness of cardiac masses in children and to point out diagnostic hints toward a cardiac tumor on various imaging modalities. Given the rarity of all tumors involving the heart and the lack of symptom specificity, a high degree of suspicion is needed to arrive at the correct diagnosis.